Thursday, November 8, 2018

EMVO has distributed the Letter announcing the release of the new Participation Agreement, covering the Operational Phase also available for the OBPs in the On-boarding Partner Portal.

Also, the Letter detailing the necessity for the OBPs to have a letter of adhesion signed by each MAH they would like to represent and upload data for in the EU Hub, is hereby attached.

 

Please find both letters as attachments.

Thursday, October 18, 2018

European Commission, European Medicines Agency and Heads of Medicines Agency issued a letter to the stakeholder on obligation deriving form the Falsified Medicines Directive 2011/62/EU.

Please find the letter below.

Thursday, October 25, 2018

EMVO guidelines for definition of "designated wholesalers" can be found in the presentation below.

Thursday, October 25, 2018

EMVO presents the decision of member states regarding placing the ATD on OTC medicines as well as the positions of member states regarding the coding requirements.

Thursday, October 18, 2018

We encourage all MAHs to register with EMVO. Registration with EMVO allows to send all information about serialized medicinal products from EU HUB to national repositories and verify its authenticity at the dispense points.

To register please follow the link: https://emvo-medicines.eu/pharmaceutical-companies/obp-portal/

Please find all the necessary information below.

Falsification of medicinal products

In recent years the pharmaceutical market has faced the rapidly growing and dangerous phenomenon of falsification of medicinal products.

READ MORE

Join us

We invite all persons interested in working with the National Medicines Verification System Foundation to send their applications via e-mail.

READ MORE

Contact us

Ul. Stępińska 9
00-739 Warszawa

biuro@nmvo.pl

+48 22 398 92 83

READ MORE